Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6489
    0.0000 (-0.00%)
     
  • OIL

    82.80
    -0.56 (-0.67%)
     
  • GOLD

    2,337.50
    -4.60 (-0.20%)
     
  • Bitcoin AUD

    99,437.75
    -3,214.79 (-3.13%)
     
  • CMC Crypto 200

    1,400.08
    -24.02 (-1.69%)
     
  • AUD/EUR

    0.6070
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0951
    +0.0021 (+0.19%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,465.86
    -5.61 (-0.03%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,381.74
    -121.95 (-0.32%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Better Dividend Stock: AbbVie or Viatris?

Better Dividend Stock: AbbVie or Viatris?

AbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) have a lot more in common than first glances would suggest. The two were both spun off from larger companies and now deliver above-average dividend yields. In AbbVie's case, it is the patent cliff next year for its immunology drug Humira, the top-selling drug last year other than COVID-19 vaccines.